Literature DB >> 15883030

Cloning and characterization of a novel RNA polymerase II C-terminal domain phosphatase.

Huarui Zheng1, Chaoneng Ji, Shaohua Gu, Binying Shi, Jin Wang, Yi Xie, Yumin Mao.   

Abstract

Reversible phosphorylation of RNA polymerase (RNAP) II's largest subunit C-terminal domain (CTD) is a key event during mRNA metabolism. The CTD phosphatase, FCP1, catalyzes the dephosphorylation of RNAP II and is thought to play a major role in polymerase recycling. In this study, we isolated a novel phosphatase gene by large-scale sequencing analysis of a human fetal brain cDNA library. Its cDNA is 2215 bp in length, encoding a 318-amino acid polypeptide that contains a ubiquitin-like domain and a CTD phosphatase domain. Therefore, it was termed ubiquitin-like domain containing CTD phosphatase 1 (UBLCP1). Reverse transcription PCR (RT-PCR) revealed that UBLCP1 was expressed with relatively lower levels in most adult normal tissues and higher levels in fast growing or tumor tissues. Transient transfection experiment suggested that UBLCP1 was localized in the nucleus of COS-7 cells. Significantly, UBLCP1 could dephosphorylate GST-CTD in vitro. Accordingly, UBLCP1 may play a role in the regulation of phosphorylation state of RNA polymerase II C-terminal domain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883030     DOI: 10.1016/j.bbrc.2005.04.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Expression and characterization of HSPC129, a RNA polymerase II C-terminal domain phosphatase.

Authors:  Hui Qian; Chaoneng Ji; Shuo Zhao; Jinzhong Chen; Mei Jiang; Yong Zhang; Mi Yan; Dan Zheng; Yaqiong Sun; Yi Xie; Yumin Mao
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

2.  UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity.

Authors:  Xing Guo; James L Engel; Junyu Xiao; Vincent S Tagliabracci; Xiaorong Wang; Lan Huang; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

3.  Evolutionary radiation pattern of novel protein phosphatases revealed by analysis of protein data from the completely sequenced genomes of humans, green algae, and higher plants.

Authors:  David Kerk; George Templeton; Greg B G Moorhead
Journal:  Plant Physiol       Date:  2007-12-21       Impact factor: 8.340

4.  Rough set soft computing cancer classification and network: one stone, two birds.

Authors:  Yue Zhang
Journal:  Cancer Inform       Date:  2010-07-15

Review 5.  Dephosphorylating eukaryotic RNA polymerase II.

Authors:  Joshua E Mayfield; Nathaniel T Burkholder; Yan Jessie Zhang
Journal:  Biochim Biophys Acta       Date:  2016-01-15

6.  A novel protein phosphatase is a binding partner for the protein kinase domains of UNC-89 (Obscurin) in Caenorhabditis elegans.

Authors:  Hiroshi Qadota; Lee Anne McGaha; Kristina B Mercer; Thomas J Stark; Tracey M Ferrara; Guy M Benian
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

7.  A conserved phosphatase cascade that regulates nuclear membrane biogenesis.

Authors:  Youngjun Kim; Matthew S Gentry; Thurl E Harris; Sandra E Wiley; John C Lawrence; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

8.  Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1.

Authors:  Yan Zhang; Youngjun Kim; Nicolas Genoud; Jianmin Gao; Jeffery W Kelly; Samuel L Pfaff; Gordon N Gill; Jack E Dixon; Joseph P Noel
Journal:  Mol Cell       Date:  2006-12-08       Impact factor: 17.970

9.  Solution structure and Rpn1 interaction of the UBL domain of human RNA polymerase II C-terminal domain phosphatase.

Authors:  Ji-Hye Yun; Sunggeon Ko; Chung-Kyung Lee; Hae-Kap Cheong; Chaejoon Cheong; Jong-Bok Yoon; Weontae Lee
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  The genetic control of neocortex volume and covariation with neocortical gene expression in mice.

Authors:  Shiv M Gaglani; Lu Lu; Robert W Williams; Glenn D Rosen
Journal:  BMC Neurosci       Date:  2009-05-09       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.